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OBJECTIVES: The aims of this study were to measure levels of sleep, stress, and depression, as well as health-related
quality of life, and to assess the neurocognitive profiles in a sample of adolescents with idiopathic musculoskeletal
pain.
METHODS: Nineteen adolescents with idiopathic musculoskeletal pain and 20 age-matched healthy control subjects
were evaluated regarding their levels of sleep and stress, as well as quality of life, and underwent neurocognitive
testing.
RESULTS: The sample groups consisted predominantly of females (84%), and the socioeconomic status did not differ
between the two groups. In addition, the occurrence of depressive symptoms was similar between the two groups;
specifically, 26% of the idiopathic musculoskeletal pain patients and 30% of the control subjects had scores
indicative of depression. Teenagers in the group with idiopathic musculoskeletal pain reported poorer quality of life
and sleep scores than those in the control group. Regarding stress, patients had worse scores than the control
group; whereas 79% of the adolescents with idiopathic musculoskeletal pain met the criteria for a diagnosis of
stress, only 35% of the adolescents in the control group met the criteria. In both groups, we observed scores that
classified adolescents as being in the resistance phase (intermediate) and exhaustion phase (pathological) of
distress. However, the idiopathic musculoskeletal pain group more frequently reported symptomatic complaints of
physical and emotional distress. The neurocognitive assessment showed no significant impairments in either group.
CONCLUSION: Adolescents with idiopathic musculoskeletal pain did not exhibit cognitive impairments. However,
adolescents with idiopathic musculoskeletal pain did experience intermediate to advanced psychological distress
and lower health-related quality of life, which may increase their risk of cognitive dysfunction in the future.
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INTRODUCTION
Musculoskeletal pain is a common complaint in children
and adolescents, presenting in 1 to 15% of the apparently
healthy population (1–3). Idiopathic musculoskeletal pain
(IMP) is defined as the presence of intermittent pain in three
or more body regions for a period exceeding three months
(4) that cannot be explained by any other particular disease.
IMP appears predominantly in females between 5 and 15
years of age (5).
Recent studies have shown that IMP pain symptoms are
the result of several factors and that the etiology of
musculoskeletal pain must therefore have multiple causes,
which may be correlated. Intrinsic factors include a low
threshold for pain, female gender, the presence of hyper-
mobility and stress. Extrinsic factors include previous
painful experiences, social deprivation, physical and sexual
abuse, parental behavior models, pain, sleep disturbances
and low physical fitness (6–10). Moreover, cognitive deficits
and emotional distress may decrease the ability to cope with
pain and other stress factors associated with chronic disease
(11,12).
Sleep disorders may lower the threshold for pain (13), and the
interaction between sleep and pain probably varies according to
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individual differences in psychological and behavioral sensi-
tivity. One possibility presented in the literature for the origin
of these symptoms is the involvement of the hypothalamic-
pituitary-adrenal (HPA) axis, suggesting that the origin of the
symptoms of fibromyalgia and IMP is related to stress
responses (13).
A wider understanding that adolescents and young
adults are susceptible to external stimuli and psychosocial
distress is essential for the development of effective IMP
management. In addition, because stress manifests both
psychologically and physically, the differential diagnosis
between physical and mental morbidity is not always easy.
Changes in cognitive functioning and mood abnormalities
may also be observed in patients with IMP. Neuropsycho-
logical studies have shown impairments in functions such as
memory and attention in adults with fibromyalgia (one of the
primary types of IMP) (14–17). However, we did not find
neurocognitive studies that focused on children and adoles-
cents with musculoskeletal pain in the current literature.
In our clinical practice, we have observed the adverse
outcomes of IMP in children and adolescents, which include
frequent absence from school, difficulty in social relation-
ships, and greater demand for family care, leading to financial
stress and work absences due to medical appointments.
In response to the lack of studies on cognitive functioning,
sleep, stress, neurocognitive profiles and health-related
quality of life (HRQL) in children and adolescents with
IMP, our objectives in this study were the following: 1) to
assess the neurocognitive functioning of IMP patients to
determine whether there is an early occurrence of cognitive
deficits (which have been thoroughly documented in adults)
and 2) to investigate factors such as sleep, stress, depression,
family history of pain, behavior and HRQL in a clinical
sample of IMP patients.
METHODS
Study design: This study had a cross-sectional
design.
Patients: Our Pediatric Musculoskeletal Pain Outpatient
Clinic opened in May 2008 as part of the Pediatric
Rheumatology Unit, Department of Pediatrics. It is coordi-
nated by three pediatric rheumatologists and consists of a
team of pediatricians, psychologists, nutritionists, physical
therapists, a social worker, and a dentist. All cases were
evaluated and discussed by the entire team. Since 2008, 120
patients with IMP between 4 and 18 years of age have been
assessed. In the present study, we included consecutive
patients with an IMP diagnosis.
Study group: Thirty-nine adolescents, aged 13–16 years,
of both genders were divided into two groups: a) 19 patients
with IMP randomly selected according to their availability
to participate in the study and b) 20 control adolescents
matched for gender, age, level of education, and socio-
economic level. The age group for this study was deter-
mined according to standardizations required by the tests
used in the assessment protocol.
Exclusion criteria for both groups included the presence
of neurological comorbidity (e.g., epilepsy, tumors, head
trauma); psychiatric disorder (e.g., personality disorders,
severe depression, and diagnosed anxiety disorders); mal-
nutrition (measured by means of clinical examination); and
low non-verbal reasoning (up to a score of 25, as measured
by Raven’s Colored Progressive Matrices (18)). In addition,
participants who had taken any psychotropic medication for
at least six months prior to the study were excluded.
Controls: The control group comprised healthy adoles-
cents, without chronic diseases or rheumatic complaints,
attending routine clinical follow-up visits at the Department
of Pediatrics Adolescence Outpatient Clinic.
Procedures
The study was approved by the local ethics committee
(protocol 0461/08). Adolescents and their parents signed a
consent form. Subjects were evaluated individually by the
same psychologist (J.M.), who was trained and experienced
in the use of evaluative techniques. Evaluations took place
in a soundproof, closed room where the subjects’ responses
would not be affected by external stimuli.
Evaluations: The interview was adapted from a survey
designed by Santos (2002) (19) and investigated clinical,
neuromotor, and psychosocial development. The question-
naire included items related to pregnancy, birth and devel-
opment, schooling achievements and possible learning and/
or health problems.
The behavioral assessment consisted of the following
scales and inventories:
1. Survey on socioeconomic class [Scale for Assessment of
Socioeconomic Status by the Brazilian Association of
Research Companies ABEP/2008 (ANEP, Associac¸a˜o
Nacional de Empresas de Pesquisa) (20); participants
were classified into five categories: Class A (35–46
points), Class B (23–34 points), Class C (14–21 points),
Class D (8–13 points), and Class E (0 to points 7 points).
2. Depression (Beck Depression Inventory, BDI) (21);
scores.9 were indicative of a depressive status.
3. HRQL – Global Scale for Quality of Life (EGQV) (22).
4. Quality of sleep (Sleep Disturbance Scale for Children,
SDSC) (23).
5. Screening for behavioral and attention abnormalities
[Assessment for Attention Deficit Hyperactivity Disorder
(EDAH, Escala para la evaluacio´n del transtorno por de´ficit
de atencio´n com hiperatividad] (24); scores.12 were
suggestive of behavioral and attention abnormalities.
6. Psychological distress (Lipp’s Stress Symptoms Inventory
for Adults, LSSI) (25); LSSI identifies and classifies
physical and psychological symptoms according to the
three stages of stress: alarm (initial stage - .6 points in
domain A), resistance (intermediary stage - .3 points in
domain B), and exhaustion (stage when diseases may
occur in more susceptible organs -.8 points in domain C).
A neuropsychological assessment was performed using
the following tests:
1. Raven’s Progressive Matrices Test: measures general
intelligence (18).
2. Brazilian Children’s Test of Pseudoword Repetition (26):
assesses the ‘phonological loop’ component of working
memory.
3. Semantic and Phonologic Verbal Fluency Test (27):
measures semantic memory and executive function. For
the semantic fluency assessment, the ‘Animals’ category
was utilized, and to assess phonologic fluency, the letters
F, A, and S were utilized.
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4. Digit span (28): forward order assesses short-term
memory, and reverse order assesses working memory.
5. Corsi Block-Tapping Test (29): forward order assesses
visual-spatial short-term memory, and reverse order
assesses the central executive component of working
memory.
6. BEM-144 Visual Memory: A) Visual Recognition of
Abstract Patterns (VRAP) and B) Complex Figure Copy
and Reproduction (FCS) (30); measures episodic memory.
7. Free words recall (31): assesses episodic memory and
consists of two word lists of 15 words each (List 1: words
with no semantic association and List 2: triad of words
semantically related by positions 7, 8, and 9 on the list
and having no semantic association in other positions);
also assesses semantic categorization in information
recall, i.e., a higher number of words are recalled due
to semantic similarity between some of them.
8. WMS Story Recall (32): measures long-term memory of
short stories with information semantically arranged.
For the VRAP (item 6A), Free words recall (item 7), and
WMS Story Recall (item 8) tasks, participants were
requested to perform an immediate recall and a delayed
recall after a 20-minute interval. In the FCS test (item 6B),
before immediate and delayed recall, participants were also
asked to do a copy of the drawing as a measurement of
visual-constructive functions.
Statistical analyses
Collected data were analyzed with STATISTICA software
(StatSoft Incorporation 1984–2004, Version 7.0).
The results of the descriptive data analyses were obtained
in terms of the means, standard deviations, and percen-
tages. For inferential analyses, the Student t-test was carried
out to compare scores between the pain group and the
control group in the neuropsychological tests and beha-
vioral scales. An additional analysis was performed, using
Tukey HSD Test and unequal HSD Test, in order to
complete the analysis of the obtained results. Contrasts in
the results of the participants inside the group, when
observed, were analyzed with Tukey HSD Test and an
unequal HSD Test. A significance level of 5% was used.
RESULTS
There was a predominance of females among the study
population (16/19 in the IMP group [84%] and 17/20 in the
control group [85%]). The demographics of the study
population are presented in Table 1. The socioeconomic
classification of the sample was similar between the two
groups (p= 0.48), with most subjects were classified in the
B2 class.
There were no differences between the two groups with
respect to symptoms of hyperactivity and attention deficit
(EDAH). The EDAH scores were below the cutoff point for
hyperactivity and attention deficit. With regard to the BDI
scale, five patients (26%) in the IMP group presented scores
indicative of depression (score .9), whereas five partici-
pants (25%) presented the same indicative of depression in
the control group. These subjects were referred for a clinical
psychological consultation. It should be noted that the scales
were not used to confirm the diagnosis of depression and
anxiety but were only used as screening tools.
Concerning the HRQL as assessed from the EGQV,
significantly lower scores were found in the IMP group
compared with the control group (p = 0.0318). In addi-
tion, significantly lower sleep scores, as measured by the
SDSC scale, were noted in the IMP group (p = 0.0361)
(Table 2).
Regarding distress, LSSI scale analysis was performed
according to distress stages (alarm, resistance, and exhaus-
tion), and differences were observed between the IMP and
control groups. The total LSSI scale score showed that 79%
of the adolescents in the IMP group met the criteria for a
stress diagnosis, whereas only 35% of the control adoles-
cents met these criteria. Both groups showed a predomi-
nance of distress in the resistance stage. In addition,
adolescents with IMP had significantly higher scores in
the resistance stage (p= 0.009) and the exhaustion stage
(p= 0.023) (Table 3). Furthermore, IMP patients presented
more symptomatic complaints of stress than the control
group in both the physical (p= 0.013) and emotional
(p= 0.030) aspects of stress.
We observed differences in performance between the two
groups in immediate recall during the neuropsychological
assessment free recall test (list 2). Specifically, the control
group performed better than the IMP group (p= 0.05).
The results obtained from all neuropsychological tests are
presented in Table 2. Additional exploratory analyses of
variance or t-tests were conducted by subdividing the
sample into two subgroups (group 1 = 13- and 14-year-olds,
N = 12; group 2 = 15- and 16-year-olds, N = 27) as indepen-
dent variables to investigate age-related differences in
neurocognitive tasks. However, there were no significant
differences between the two age groups.
Table 1 - Demographics of and behavioral scale scores [mean¡(SD)] in the sample population.
IMP Group (N = 19) Control Group (N = 20)
Mean (SD) Min-Max Mean (SD) Min-Max t-value p-value
Age (y) 14.7 (0.99) 13–16 14.7 (0.97) 13–16 20.42 0.96
Schooling (y) 8.5 (1.26) 6–11 8.6 (1.23) 6–11 20.05 0.95
ABEP 23.7 (4.85) 15–33 25.5 (4.78) 15–33 21.14 0.26
SDSC 29.3 (12.57) 8–56 20.5 (13.02) 6–42 2.17 0.03*
EGQV 17.2 (3.99) 4–22 19.4 (1.76) 16–23 22.23 0.03*
BDI 7.6 (6.16) 0–21 5.31(5.15) 0–15 1.31 0.19
Pain onset age 8.95(3.46) 3–13 - - -
IMP Group=group of adolescents with musculoskeletal pain; SD= standard deviation; Min-Max =minimum and maximum values of the obtained scores;
ABEP= Scale for Socioeconomic Class Status; SDSC= Sleep disorder scale for children; EGQV=Global Scale for Quality of Life; BDI =Beck’s Depression
Inventory; (*) significant results based on the Student’s t-test.
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DISCUSSION
Some physicians who follow children and adolescents
with recurrent pain consider the physical but not the
psychological aspects of pain. This perspective may lead
to incomplete and ineffective treatment approaches, result-
ing in symptom persistence and a subsequent significant
decrease in HRQL. The main objective of this study was to
assess the neurocognitive profile of patients with IMP
compared with a control group, with a focus on possible
memory impairments. Furthermore, the occurrence of
stress, depression, behavioral disturbances and quality of
life were assessed.
Our finding of a predominance of IMP in females (84%)
corroborates previous reports in the literature (5). Gedalia
et al. (33) evaluated 59 children and adolescents with
musculoskeletal pain and found that 80% were female. The
prevalence of IMP among females is hypothesized to be a
result of the following factors: genetic, hormonal, and
environmental (34). In addition, factors related to hyper-
sensitivity may also be involved (35). Garcia et al. (35)
investigated differences in the pain threshold for healthy
individuals, and they found a lower pain threshold for pain
trigger points in women compared with age-matched men.
Research on the etiopathogenesis of fibromyalgia has
shown psychological factors to be core IMP elements in
adults and children (36–38). For the clinical diagnosis of
mood (affective) disorders, a detailed psychiatric history is
very important; however, the BDI scale is a reliable tool that
aids in depression screening and in the recognition of
subclinical markers that do not achieve the required criteria
for a formal diagnosis (but suggests the possibility of future
psychiatric disorders). In our sample, no difference was
found between the groups with regard to the occurrence of
depressive symptoms, as described in other studies invol-
ving adult subjects (39,40). In addition, our data are
consistent with those of studies performed in adolescents
with IMP (36). In another study, the detection (39) of
depressive symptoms was based on an analysis of patient
surveys, which did not include a control group. The results
indicated that adolescents who fulfilled the criteria for a
diagnosis of fibromyalgia presented higher susceptibility to
emotional difficulties and were at risk of developing
psychiatric comorbidities similar to those seen in adults
(75 to 81%) (41).
Complaints regarding stress and sleep changes are direct-
ly related to chronic and recurrent pain in both animal and
human models (42,43). In addition, studies have demon-
strated the impact of stress and poor sleep quality on HRQL
(44). According to Graham and Streitel (45), pain may lead
to sleep disorders and behavioral disturbances possibly
because patients with pain exhibit an increased perception
Table 2 - Neuropsychological assessment in adolescents with IMP (N=19) and controls (N=20) (mean¡[SD]).
Test scores IMP Group Control Group
Mean (SD) Min-Max Mean (SD) Min-Max t-value p-value
Raven’s Progressive Matrices Percentile 47.10 (3.36) 42–55 46.50 (1.82) 43–49 0.70 0.17
BCPR 37.42 (1.95) 33–40 38.20 (0.77) 37–40 –1.65 0.12
V.F. Letter F 9.90 (3.71) 3–16 9.65 (2.58) 5–15 0.24 0.81
V.F. Letter A 9.05 (3.06) 4–17 8.45 (2.30) 4–14 0.69 0.49
V.F. Letter S 8.05 (2.90) 3–14 9.20 (2.40) 6–14 21.35 0.18
V.F. Animals 16.21 (2.92) 10–22 17.20 (2.57) 13–24 21.12 0.27
Forward Digit span 7.89 (2.16) 5–13 8.30 (1.21) 6–10 20.72 0.48
Backward Digit span 5.26 (1.79) 3–9 6.05 (1.54) 6–10 21.47 0.15
FO Corsi’s span 5.47 (1.26) 3–8 5.5 (0.76) 4–7 20.07 0.94
BO Corsi’s span 5.21 (1.03) 4–7 5.65 (0.93) 4–7 21.39 0.17
I VRAP 18.53 (3.75) 11–24 19.25 (3.96) 11–23 20.59 0.56
D VRAP 18.05 (4.17) 10–24 19.50 (3.31) 11–23 21.20 0.24
FCS C 9.37 (1.31) 6.5–12 9.37 (1.57) 7–12 20.14 0.99
FCS IR 6.10 (2.38) 2.5–10 6.72 (2.04) 3–11.5 20.87 0.39
FCS LR 5.79 (2.17) 3–9.5 5.87 (1.91) 2.5–10 20.13 0.90
I Word List 1 5.63 (1.67) 3–9 6 (1.62) 4–10 20.70 0.49
D Word List 1 3.31 (1.67) 1–7 2.75 (1.62) 0–6 1.07 0.29
I Word List 2 5.05 (2.30) 1–9 6.4 (1.96) 3–10 21.97 0.05*
D Word List 2 2.68 (1.97) 0–6 3.35 (1.46) 1–6 21.20 0.24
I WMS Story 1 14.68 (4.41) 7–25 15 (3.23) 9–21 20.25 0.80
D WMS Story 1 12.89 (3.23) 6–19 13 (3.42) 7–18 20.09 0.92
I WMS Story 2 13.16 (3.93) 7–20 11 (3.85) 4–18 1.73 0.09
D WMS Story 2 12.10 (3.16) 7–17 10.15 (4.34) 2–18 1.60 0.12
BCPR=Brazilian Children’s Test of Pseudoword Repetition; V.F. =Verbal fluency; FO= forward order; BO=backward order; I = immediate recall;
D =delayed recall; FCS C= FCS Task - Copy; FCS IR = FCS Task – Immediate Reproduction; FCS LR= FCS Task – Late Reproduction. (*) significant result based
on the Student’s t-test.
Table 3 - Lipp’s Stress Symptoms Inventory for Adults (LSSI; mean¡[SD]).
IMP Group (N = 19) Control Group (N = 20)
Distress stages Mean (SD) Min-Max Mean (SD) Min-Max t-value p-value
Alarm 3.63 (2.71) 0–10 2.2 (1.64) 0–5 2.00 0.05
Resistance 5.60 (3.25) 1–12 3.15 (2.18) 0–8 2.75 0.009
Exhaustion 5.47 (3.33) 0–12 3.20 (2.66) 0–10 2.35 0.02
IMP Group=group of adolescents with musculoskeletal pain; SD= standard deviation; Min-Max =minimum and maximum values of the obtained scores.
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of psychological stressors in several life aspects (for
example, in family, school and social situations) compared
with individuals without chronic pain.
Because stress responses were increased among IMP
adolescents, it is likely that these individuals may reach a
state of exhaustion while coping. In addition, these authors
argued that psychological stress, in general, can amplify the
association between pain and sleep. Intense pain itself is a
powerful stressor, leading to a "snowballing" effect. In our
sample, adolescents with chronic pain exhibited higher
levels of stress and sleep dysfunction and worse quality of
life compared with the control group. The association
between depressed mood, stress, pain and sleep dysfunc-
tion is likely to be particularly strong in young people who
are still developing their abilities to regulate emotion,
attention, and behavioral responses to stress (13). Taken
together, these findings and those of other studies (13)
suggest that multiple stressors may increase the risk of
behavioral and health problems, such as the development of
anxiety disorders and mood swings.
The results of the neurocognitive assessment indicated
that memory deficits were absent, with the exception of the
immediate free recall of one 15-item word list. In particular,
list 2 assessed the storage of semantic-related words (e.g.,
milk, cheese, and butter) in intermediary positions (7, 8, and
9). The presence of semantic-related words in intermediary
positions leads to a higher item recall due to semantic
association (31,46) in healthy subjects. However, although
the IMP group of adolescents had been shown to under-
perform compared with their peers, it is unknown why
these adolescents did not take advantage of semantic
associations to improve their recall. However, this finding
is not very robust because only a single list was used; thus,
further investigation is needed (46).
Overall, there were no differences between groups with
regard to the measurements of episodic memory in both
immediate and delayed recall in either verbal or visuospa-
tial modalities. Therefore, adolescents with IMP exhibited a
mnemonic neurocognitive profile similar to that of adoles-
cents without pain. Our findings are different from those of
studies using adults (11,12,14–16,45), in which memory
deficits were demonstrated.
Some studies showed a more favorable IMP prognosis for
adolescents than adults (48,49). However, a follow-up study
showed that 80 to 90% of adolescents still report pain after 2
to 3 years (50). Therefore, if individuals with chronic IMP
are more affected, it is possible that the present sample
failed to show neurocognitive disorders because the subjects
were in the early stages of progression in both IMP and
emotional distress. However, further studies on adolescents
are necessary to develop a deeper understanding of the
impact of IMP over time.
Many unanswered questions remain in the area of
musculoskeletal pain. One of the most pressing questions
refers to how chronic diseases are related to psychiatric
symptoms of depression and anxiety: are anxiety and mood
disorders the consequences of experiencing symptoms of
chronic diseases, or do they fall within the same disease
spectrum because they share common risk factors? This
study demonstrated the vulnerability of adolescents facing
emotional difficulties, taking into account the indicators of
stress and depression. Our findings are important because
an estimated 75 to 81% of adults meet the criteria for
fibromyalgia at least once in their lifetime (51), according to
psychiatric diagnoses.
Our findings highlight the need for more comprehensive
care for this population, which could be accomplished with
interdisciplinary teams consisting of pediatricians, psycholo-
gists, nutritionists, and physical therapists. Such collaborative
efforts in somatic pain treatment would allow for an inte-
grative view of the individual as a whole. Our observations
justify this point of view, as a positive relationship was found
between reduced quality of life and stress levels. However, a
more thorough exploration of the cognitive, social and
emotional consequences of IMP with a larger number of
patients is necessary. Furthermore, a comparison of the
neurocognitive functioning between adolescents with idio-
pathic pain and adolescents with organically based pain (e.g.,
chronic arthropathies) is also needed.
Methodological limitations of the current study included
a small sample size and the absence of highly specific
measurements of anxiety and mood disorders. However, a
more complete investigation of the emotional, social, and
cognitive aspects of the lives of adolescents with IMP is
ongoing and includes a larger sample size and comparisons
of neurocognitive functioning between adolescents with
idiopathic pain and adolescents with organically based
pain. The current study was initiated before the creation of
the PedIMMPACT guidelines established in 2008, which
explains the absence of the rating scales for pain and
functional capacity that are now considered the gold
standard in pain evaluation. The use of these guidelines
will also be addressed in our subsequent study.
We believe that traditional and individual interventions
are of great importance in the effort to minimize future
impairments in the quality of life of IMP patients. Finally,
longitudinal studies must be conducted to increase the
understanding of how chronic pain leads to memory
impairment as a long-term outcome.
Despite the frequency of complaints related to difficulties
in memory, there is no evidence of relevant deficits in
memory of adolescents with IMP. However, there is
evidence that adolescents with IMP experience symptoms
of intermediate to advanced phases of stress, alterations in
sleep and poorer quality of life compared to adolescents
without chronic pain.
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